WORCESTER, Mass., Oct. 14, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it will host a conference call on Thursday, October 15, 2009 at 11:00 a.m. Eastern Daylight Time to update the investment community on the Company’s flagship product, Generex Oral-lyn(TM) and other corporate activities.
